IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$535.54 USD
+1.23 (0.23%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $535.67 +0.13 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, IDEXX Laboratories, Inc. has a PEG ratio of 4.29 compared to the Medical - Instruments industry's PEG ratio of 2.25.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IDXX 535.54 +1.23(0.23%)
Will IDXX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IDXX
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Idexx (IDXX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Other News for IDXX
IDEXX Laboratories Q2 2025 Earnings Preview
Earnings Outlook For IDEXX Laboratories
Baron Focused Growth Fund Q2 2025 Shareholder Letter
Why Investors Are Eyeing IDEXX Laboratories Inc (IDXX): The Key Drivers of Market ...
IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals | ...